MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway.

Wang R, Xu Y, Niu X, Fang Y, Guo D, Chen J, Zhu H, Dong J, Zhao R, Wang Y, Qi B, Ren G, Li X, Liu L, Zhang M

DOI: 10.3389/fphys.2021.646903
Published: 2021
Container: Frontiers in physiology
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphys.2021.646903,
  title = {MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway.},
  author = {Wang R and Xu Y and Niu X and Fang Y and Guo D and Chen J and Zhu H and Dong J and Zhao R and Wang Y and Qi B and Ren G and Li X and Liu L and Zhang M},
  year = {2021},
  journal = {Frontiers in physiology},
  doi = {10.3389/fphys.2021.646903},
  url = {https://doi.org/10.3389/fphys.2021.646903}
}

RIS

TY  - JOUR
TI  - MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway.
AU  - Wang R
AU  - Xu Y
AU  - Niu X
AU  - Fang Y
AU  - Guo D
AU  - Chen J
AU  - Zhu H
AU  - Dong J
AU  - Zhao R
AU  - Wang Y
AU  - Qi B
AU  - Ren G
AU  - Li X
AU  - Liu L
AU  - Zhang M
PY  - 2021
JO  - Frontiers in physiology
DO  - 10.3389/fphys.2021.646903
UR  - https://doi.org/10.3389/fphys.2021.646903
ER  -

APA

R, W., Y, X., X, N., Y, F., D, G., J, C., H, Z., J, D., R, Z., Y, W., B, Q., G, R., X, L., L, L., & M, Z. (2021). MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway.. Frontiers in physiology. https://doi.org/10.3389/fphys.2021.646903

Source records

pubmed · retrieved 2026-09-25T01:18:27.915Z
europe-pmc · retrieved 2026-09-25T01:18:27.972Z
doaj · retrieved 2026-09-25T01:18:27.914Z